Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Aug 25, 2016 $1.95 $1.95 $1.90 $1.94 41 300
Aug 24, 2016 $1.94 $2.01 $1.90 $1.93 110 100
Aug 23, 2016 $1.93 $1.96 $1.90 $1.93 38 100
Aug 22, 2016 $1.91 $1.98 $1.88 $1.93 41 500
Aug 19, 2016 $1.90 $1.93 $1.90 $1.91 25 400
Aug 18, 2016 $1.92 $1.92 $1.90 $1.91 88 700
Aug 17, 2016 $1.95 $2.00 $1.92 $1.93 36 900
Aug 16, 2016 $1.96 $1.96 $1.93 $1.95 19 600
Aug 15, 2016 $1.99 $2.00 $1.88 $1.98 87 300
Aug 12, 2016 $1.95 $1.99 $1.93 $1.97 45 600
Aug 11, 2016 $1.90 $1.99 $1.86 $1.96 43 700
Aug 10, 2016 $2.00 $2.00 $1.87 $1.88 127 800
Aug 09, 2016 $2.02 $2.07 $1.83 $1.98 282 000
Aug 08, 2016 $2.12 $2.12 $2.01 $2.04 182 000
Aug 05, 2016 $2.17 $2.22 $2.05 $2.14 130 500
Aug 04, 2016 $2.40 $2.42 $2.14 $2.16 199 700
Aug 03, 2016 $2.30 $2.42 $2.27 $2.37 127 200
Aug 02, 2016 $2.28 $2.40 $2.28 $2.33 144 400
Aug 01, 2016 $2.24 $2.35 $2.23 $2.29 114 100
Jul 29, 2016 $2.30 $2.32 $2.21 $2.26 44 200
Jul 28, 2016 $2.36 $2.38 $2.27 $2.29 25 000
Jul 27, 2016 $2.35 $2.42 $2.21 $2.34 58 100
Jul 26, 2016 $2.30 $2.34 $2.27 $2.33 64 700
Jul 25, 2016 $2.22 $2.29 $2.20 $2.28 123 600
Jul 22, 2016 $2.19 $2.21 $2.17 $2.20 45 400
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT